Growth Metrics

Rigel Pharmaceuticals (RIGL) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -68.29%
Jun 30, 2025 -68.55%
Mar 31, 2025 -67.13%
Dec 31, 2024 -65.21%
Sep 30, 2024 -66.59%
Jun 30, 2024 -64.92%
Mar 31, 2024 -61.73%
Dec 31, 2023 -60.49%
Sep 30, 2023 -57.74%
Jun 30, 2023 -55.14%
Mar 31, 2023 -51.61%
Dec 31, 2022 -26.51%
Sep 30, 2022 -0.47%
Jun 30, 2022 6.14%
Mar 31, 2022 10.18%
Dec 31, 2021 16.34%
Sep 30, 2021 21.48%
Jun 30, 2021 21.55%
Mar 31, 2021 20.18%
Dec 31, 2020 45.15%
Sep 30, 2020 39.91%
Jun 30, 2020 34.34%
Mar 31, 2020 34.27%
Dec 31, 2019 23.15%
Sep 30, 2019 9.91%
Jun 30, 2019 -1.04%
Mar 31, 2019 -0.21%
Dec 31, 2018 -4.91%
Sep 30, 2018 -6.59%
Jun 30, 2018 -6.41%
Mar 31, 2018 -11.92%
Dec 31, 2017 -29.61%
Sep 30, 2017 -31.52%
Jun 30, 2017 -34.09%
Mar 31, 2017 -35.41%
Dec 31, 2016 -36.22%
Sep 30, 2016 -36.01%
Jun 30, 2016 -33.82%
Mar 31, 2016 -34.89%
Dec 31, 2015 -34.82%
Sep 30, 2015 -32.32%
Jun 30, 2015 -33.35%
Mar 31, 2015 -29.08%
Dec 31, 2014 -19.90%
Sep 30, 2014 -18.17%
Jun 30, 2014 -12.77%
Dec 31, 2013 -0.58%